Gustavo Mahler is the current Chief Executive Officer of Cellistic and Ncardia. Previously, Mahler has held various executive positions in companies such as Dynamk Capital LLC, Life Science Washington, AGC Biologics, CMC Icos Biologics, AbSci, Bayer Healthcare, and Bayer. With a strong background in Biochemistry and Business, Mahler has significant experience in leading global operations, sales, marketing, and manufacturing in the biotechnology industry.
Sign up to view 4 direct reports
Get started